The company is considering selling assets that could be more easily separated from the rest of the business without creating ...
The Medicare giant likes what it’s seen in the first two weeks of open enrollment. But there are steps it can take if ...
Prospect Medical Holdings is seeking approval from a bankruptcy court to close its hospitals in Rhode Island. Regulators and ...
Leaders are worried some of the sector’s persistent challenges — like finance pressures and worker burnout — could worsen ...
Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...
Researchers said the results suggest UnitedHealth may be sidestepping government rules meant to keep a lid on exorbitant ...
The hospital operator will invest more in organic hospital growth and high-acuity service lines as it sees strong demand for ...
Dr. Cliff Deveny announced the transition less than a month after General Catalyst finalized its $515 million acquisition of Summa.
Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.
Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...
The goodwill impairment charge is meant to realign Centene’s value on its own books with its value in the market, which has ...
Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback